Metabolites
Displaying metabolites 1126 - 1150 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB21582 | Ubiquinone-3 | 2,3-dimethoxy-5-methyl-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]cyclohexa-2,5-diene-1,4-dione | TCA cycle (ubiquinol-3) PW001003 | 386.5244 C24H34O4 | |
ECMDB01245 | dCDP 800-73-7 | [({[(2R,3S,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | Pyrimidine metabolism PW000942 | 387.177 C9H15N3O10P2 | |
ECMDB01000 | dUDP | [({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | Pyrimidine metabolism PW000942 | 388.1618 C9H14N2O11P2 | |
ECMDB23728 | Deoxyuridine-5'-diphosphate | [({[(2S,3R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | 388.1618 C9H14N2O11P2 | ||
ECMDB21576 | Ubiquinol-3 | 2,3-dimethoxy-5-methyl-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,4-diol | TCA cycle (ubiquinol-3) PW001003 | 388.5402 C24H36O4 | |
ECMDB00280 | Phosphoribosyl pyrophosphate 7540-64-9 | [({[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]oxy}(hydroxy)phosphoryl)oxy]phosphonic acid | NAD salvage PW000830 More...PRPP Biosynthesis PW000909 Secondary Metabolites: Histidine biosynthesis PW000984 histidine biosynthesis PW000810 purine nucleotides de novo biosynthesis PW000910 purine nucleotides de novo biosynthesis 1435709748 PW000960 tryptophan metabolism II PW001916 Thiamin diphosphate biosynthesis PW002028 adenine and adenosine salvage I PW002069 adenine and adenosine salvage III PW002072 guanine and guanosine salvage PW002074 purine nucleotides de novo biosynthesis 2 PW002033 purine ribonucleosides degradation PW002076 | 390.0696 C5H13O14P3 | |
ECMDB20573 | L-Ala-D-Glu-meso-A2pm | (2R,6S)-2-amino-6-{[(4R)-4-{[(2S)-2-amino-1-hydroxypropylidene]amino}-4-carboxy-1-hydroxybutylidene]amino}heptanedioic acid | 390.3889 C15H26N4O8 | ||
ECMDB24044 | 12-Ketodeoxycholic acid | (4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R)-5-hydroxy-2,15-dimethyl-16-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid | 390.5561 C24H38O4 | ||
ECMDB21387 | Deoxycholic acid 83-44-3 | (4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R,16S)-5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid | inner membrane transport PW000786 | 392.572 C24H40O4 | |
ECMDB23433 | 3-(all-trans-pentaprenyl)benzene-1,2-diol | 3-[(2E,5E,8E,11E,14E,17E,20E)-3,6,9,12,15,18,21,24-octamethylpentacosa-2,5,8,11,14,17,20,23-octaen-1-yl]benzene-1,2-diol | 394.5894 C27H38O2 | ||
ECMDB21113 | 1-Acyl-sn-glycero-3-phosphoethanolamine (N-C12:0) | (2-aminoethoxy)[3-(dodecanoyloxy)-2-hydroxypropoxy]phosphinic acid | 397.444 C17H36NO7P | ||
ECMDB21139 | 2-Acyl-sn-glycero-3-phosphoethanolamine (N-C12:0) | (2-aminoethoxy)[2-(dodecanoyloxy)-3-hydroxypropoxy]phosphinic acid | 397.444 C17H36NO7P | ||
ECMDB21330 | Ethanesulfonate 59721-29-8 | 4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate | 398.4125 C20H22N4O5 | ||
ECMDB21282 | S-Adenosyl-4-methylthio-2-oxobutanoate | {[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(3-carboxy-3-oxopropyl)methylsulfanium | Biotin metabolism PW000762 | 398.414 C15H20N5O6S | |
ECMDB01185 | S-Adenosylmethionine 29908-03-0 | [(3S)-3-amino-3-carboxypropyl]({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl})methylsulfanium | 399.445 C15H23N6O5S | ||
ECMDB24024 | L-Palmitoylcarnitine | (3R)-3-(hexadecanoyloxy)-4-(trimethylazaniumyl)butanoate | 399.6077 C23H45NO4 | ||
ECMDB23241 | DG(10:0/10:0/0:0) | 3-(decanoyloxy)-2-hydroxypropyl decanoate | 400.6 C23H44O5 | ||
ECMDB01274 | dTDP 491-97-4 | {[hydroxy({[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy}phosphonic acid | 402.1884 C10H16N2O11P2 | ||
ECMDB20186 | S-(1,2-Dichlorovinyl)glutathione 96614-59-4 | (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[(E)-1,2-dichloroethenyl]sulfanyl}ethyl]-C-hydroxycarbonimidoyl}butanoic acid | 402.251 C12H17Cl2N3O6S | ||
ECMDB01117 | 4-Phosphopantothenoylcysteine 7196-09-0 | (2R)-2-{3-[(2R)-2-hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanamido}-3-sulfanylpropanoic acid | Pantothenate and CoA biosynthesis PW000828 | 402.358 C12H23N2O9PS | |
ECMDB01546 | CDP 63-38-7 | [({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | Pyrimidine metabolism PW000942 | 403.1764 C9H15N3O11P2 | |
ECMDB00295 | Uridine 5'-diphosphate 58-98-0 | [({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | Pyrimidine metabolism PW000942 Starch and sucrose metabolism PW000941 Lipopolysaccharide biosynthesis PW000831 Amino sugar and nucleotide sugar metabolism III PW000895 More...Secondary Metabolites: enterobacterial common antigen biosynthesis PW000959 peptidoglycan biosynthesis I PW000906 lipopolysaccharide biosynthesis II PW001905 Secondary Metabolites: enterobacterial common antigen biosynthesis 2 PW002045 Secondary Metabolites: enterobacterial common antigen biosynthesis 3 PW002046 lipopolysaccharide biosynthesis III PW002059 peptidoglycan biosynthesis I 2 PW002062 polymyxin resistance PW002052 trehalose biosynthesis I PW002088 | 404.1612 C9H14N2O12P2 | |
ECMDB21128 | 1-Hexadec-9-enoyl-sn-glycerol 3-phosphate | 2-hydroxy-3-(phosphonatooxy)propyl (9E)-hexadec-9-enoate | 406.4508 C19H35O7P | ||
ECMDB23869 | alpha-D-Aldose 1-phosphate | 2,8-dibenzyl-6-(4-hydroxyphenyl)-3H,7H-imidazo[1,2-a]pyrazin-3-one | Pyrimidine metabolism PW000942 | 407.473 C26H21N3O2 | |
ECMDB21160 | 2-hexadec-9-enoyl-sn-glycerol 3-phosphate | {2-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropoxy}phosphonic acid | 408.4666 C19H37O7P |